HR 8205 · 119th Congress 2025–2027

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Latest action · Nov 3, 2026 Became Public Law No: 119-138.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 6, 2026
  2. Passed HouseJul 22, 2026
  3. Passed SenateSep 28, 2026
  4. To the PresidentOct 26, 2026
  5. Became lawNov 3, 2026Public Law 119-138

Summary

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

This act reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases.

The act reauthorizes

  • grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials,
  • grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and
  • a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases. 

Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs.

Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Cosponsors 103

Members who signed on, in the order they did. Signatures ran from Apr 6, 2026 to Jul 9, 2026; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
R-CAKen CalvertOriginalApr 6, 2026
D-MNAngie CraigApr 9, 2026
R-PABrian K. FitzpatrickApr 9, 2026
D-MAJake AuchinclossApr 9, 2026
D-ILJanice D. SchakowskyApr 9, 2026
R-TXMichael T. McCaulApr 9, 2026
R-TNScott DesJarlaisApr 9, 2026
D-ILBradley Scott SchneiderApr 14, 2026
R-CADavid G. ValadaoApr 14, 2026
R-PAGlenn ThompsonApr 14, 2026
D-WIGwen MooreApr 14, 2026
D-COJason CrowApr 14, 2026
R-COJeff HurdApr 14, 2026
R-OHDavid P. JoyceApr 15, 2026
D-TXMarc A. VeaseyApr 15, 2026
R-FLMaria Elvira SalazarApr 15, 2026
D-ORSuzanne BonamiciApr 15, 2026
R-NYAndrew R. GarbarinoApr 16, 2026
D-CABrad ShermanApr 16, 2026
R-FLGus M. BilirakisApr 16, 2026
D-MAStephen F. LynchApr 16, 2026
D-WAAdam SmithApr 20, 2026
R-NEDon BaconApr 20, 2026
R-CAJay ObernolteApr 20, 2026
D-PAMadeleine DeanApr 20, 2026
R-TXPete SessionsApr 20, 2026
D-TNSteve CohenApr 20, 2026
R-OKTom ColeApr 20, 2026
D-NCValerie P. FousheeApr 20, 2026
R-FLJohn H. RutherfordApr 21, 2026
D-ALTerri A. SewellApr 21, 2026
D-ILDanny K. DavisApr 22, 2026
R-SCJoe WilsonApr 22, 2026
D-NYRitchie TorresApr 23, 2026
R-ALRobert B. AderholtApr 23, 2026
D-DCEleanor Holmes NortonApr 30, 2026
R-KSTracey MannApr 30, 2026
D-NJJefferson Van DrewMay 4, 2026
D-ILRaja KrishnamoorthiMay 4, 2026
D-WAKim SchrierMay 7, 2026
D-ILLauren UnderwoodMay 7, 2026
R-MOMark AlfordMay 7, 2026
R-NYNick LaLotaMay 7, 2026
R-NCChuck EdwardsMay 11, 2026
D-MIDebbie DingellMay 11, 2026
D-CADoris O. MatsuiMay 11, 2026
R-CAYoung KimMay 11, 2026
R-ILMike BostMay 12, 2026
D-CAMike ThompsonMay 12, 2026
D-NYPaul TonkoMay 12, 2026
R-TXRandy K. Weber, Sr.May 12, 2026
D-MIRashida TlaibMay 12, 2026
R-MITim WalbergMay 12, 2026
R-OKStephanie I. BiceMay 13, 2026
D-WASuzan K. DelBeneMay 13, 2026
R-ILDarin LaHoodMay 14, 2026
D-CAJ. Luis CorreaMay 14, 2026
R-FLMario Diaz-BalartMay 14, 2026
D-NYTimothy M. KennedyMay 14, 2026
D-CAGeorge WhitesidesMay 15, 2026
R-ARSteve WomackMay 15, 2026
R-NCDavid RouzerMay 19, 2026
D-GASanford D. Bishop, Jr.May 19, 2026
R-LAJulia LetlowMay 21, 2026
D-ILRobin L. KellyMay 21, 2026
D-NJJosh GottheimerMay 26, 2026
R-NVMark E. AmodeiMay 26, 2026
R-NCTim MooreMay 29, 2026
D-MOEmanuel CleaverJun 2, 2026
D-AZGreg StantonJun 2, 2026
R-TXJohn R. CarterJun 2, 2026
D-VAEugene Simon VindmanJun 10, 2026
R-VARobert J. WittmanJun 10, 2026
D-ORJanelle S. BynumJun 11, 2026
R-MSMichael GuestJun 11, 2026
D-AZAdelita S. GrijalvaJul 9, 2026
D-NCAlma S. AdamsJul 9, 2026
D-NJAnalilia MejiaJul 9, 2026
D-NJBonnie Watson ColemanJul 9, 2026
R-WVCarol D. MillerJul 9, 2026
D-MEChellie PingreeJul 9, 2026
D-NCDeborah K. RossJul 9, 2026
D-NCDonald G. DavisJul 9, 2026
D-ILEric SorensenJul 9, 2026
D-NYGeorge LatimerJul 9, 2026
D-OHGreg LandsmanJul 9, 2026
D-NJHerbert C. Conaway, Jr.Jul 9, 2026
D-CTJahana HayesJul 9, 2026
D-CTJames A. HimesJul 9, 2026
D-CTJohn B. LarsonJul 9, 2026
D-ILJonathan L. JacksonJul 9, 2026
D-NYJosh RileyJul 9, 2026
D-OHJoyce BeattyJul 9, 2026
D-OHMarcy KapturJul 9, 2026
D-PAMary Gay ScanlonJul 9, 2026
D-NMMelanie A. StansburyJul 9, 2026
D-ILNikki BudzinskiJul 9, 2026
D-DESarah McBrideJul 9, 2026
D-CAScott H. PetersJul 9, 2026
D-ILSean CastenJul 9, 2026
D-RISeth MagazinerJul 9, 2026
D-NYThomas R. SuozziJul 9, 2026
D-LATroy A. CarterJul 9, 2026

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 6, 2026Markup May 21, 2026Reported Jul 9, 2026
Health Subcommittee
Referred Apr 6, 2026Markup May 13, 2026Reported May 13, 2026

Actions 22

Everything that happened, newest first.

  1. Nov 3, 2026Became Public Law No: 119-138.
  2. Nov 3, 2026Signed by President.
  3. Oct 26, 2026Presented to President.
  4. Oct 14, 2026Message on Senate action sent to the House.
  5. Sep 28, 2026Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote. (consideration: CR S5120)

In the Congressional Record 3

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S5146, S5147Christopher A. Coons D-DE, Lisa Murkowski R-AKSep 29, 2026
SenateDebate and remarks S5120Mike Lee R-UTSep 28, 2026
HouseDebate and remarks H4652–H4654Text printed H4653Brett Guthrie R-KY, Diana DeGette D-CO, Ken Calvert R-CA, Mike Quigley D-ILJul 20, 2026

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article I, Section 8

The sponsor’s statement, as printed in the Congressional Record, vol. 172, no. 62, April 6, 2026, page H2825.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 4472Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026Related billAug 10, 2026

Titles 7

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.
Short Title(s) as Introduced
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Short Title(s) as Reported to House
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Short Title(s) as Passed House
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Short Titles from ENR (Enrolled) bill text
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Short Title(s) from PCS (Placed on Senate Calendar) bill text
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Official Title from EH (Engrossed in House) bill text
To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 5

Each version as it was printed, newest first.

  1. —Enrolled Bill
  2. Jul 23, 2026Placed on Calendar Senate
  3. Jul 22, 2026Engrossed in House
  4. Jul 9, 2026Reported in House
  5. Apr 6, 2026Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.